Search by Drug Name or NDC
NDC 75854-0321-30 Niferex 60; 25; 50; 250; 100; 100; 750; 50; 15 mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1 Details
Niferex 60; 25; 50; 250; 100; 100; 750; 50; 15 mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1
Niferex is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Avion Pharmaceuticals, LLC. The primary component is ASCORBIC ACID; CYANOCOBALAMIN; FERROUS ASPARTO GLYCINATE; FOLIC ACID; INTRINSIC FACTOR; IRON DEXTRAN; LEVOMEFOLIC ACID; SUCCINIC ACID; ZINC.
Product Information
NDC | 75854-0321 |
---|---|
Product ID | 75854-321_b8552673-ba5c-3d80-e053-2995a90a1fa5 |
Associated GPIs | 82992000000300 |
GCN Sequence Number | 077038 |
GCN Sequence Number Description | iron ag,ps/C/FA6/B12/Zn/sa/sto TABLET 150MG-60-1 ORAL |
HIC3 | C3B |
HIC3 Description | IRON REPLACEMENT |
GCN | 42909 |
HICL Sequence Number | 044048 |
HICL Sequence Number Description | IRON ASP GLY,POLYSACC/C/FOLATE 6/B12/ZINC GLY/SUCC AC/STOMCH |
Brand/Generic | Brand |
Proprietary Name | Niferex |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 60; 25; 50; 250; 100; 100; 750; 50; 15 |
Active Ingredient Units | mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1 |
Substance Name | ASCORBIC ACID; CYANOCOBALAMIN; FERROUS ASPARTO GLYCINATE; FOLIC ACID; INTRINSIC FACTOR; IRON DEXTRAN; LEVOMEFOLIC ACID; SUCCINIC ACID; ZINC |
Labeler Name | Avion Pharmaceuticals, LLC |
Pharmaceutical Class | Ascorbic Acid [CS], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC] |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2022-12-31 |
Package
Package Images

NDC 75854-0321-30 (75854032130)
NDC Package Code | 75854-321-30 |
---|---|
Billing NDC | 75854032130 |
Package | 30 TABLET in 1 BOTTLE (75854-321-30) |
Marketing Start Date | 2017-01-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 899f97fb-85f1-4e78-9708-b916a1646129 Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
WARNING
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
HOW SUPPLIED: Bottles of 30 tablets (75854-321-30). The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Quatrefolic® is a registered trademark of Gnosis, SpA. Covered by one or more claims of U.S. Patent #7,947,662 CAS #1181972-37-1
Sumalate® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846 and 8,425,956.
MANUFACTURED FOR:
Avion Pharmaceuticals, LLC
Alpharetta, GA 30005 1-888-61-AVION
Rev. 0119-01 AV-428
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR INTENDED TO DIAGNOSE, PREVENT ANY DISEASE.
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
NIFEREX
ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor tablet |
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
Labeler - Avion Pharmaceuticals, LLC (040348516) |
Registrant - Avion Pharmaceuticals, LLC (965450542) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Avion Pharmaceuticals, LLC | 040348516 | manufacture(75854-321) |